Beam Therapeutics

Last updated: October 09, 2024

CEO John Evans and cofounders, David Liu, Keith Joung, and Feng Zhang
CEO John Evans and cofounders, David Liu, Keith Joung, and Feng Zhang
USA | Funding: $689M (+)

Website: https://beamtx.com/

Beam Therapeutics develops of genome editing technologies.